欧林生物（688319）8月25日主力资金净流出2905.37万元

Core Points - The stock price of Olin Bio (688319) closed at 32.67 yuan, down 1.51% as of August 25, 2025 [1] - The company reported a total revenue of 87.49 million yuan for Q1 2025, representing a year-on-year growth of 23.58% [1] - Net profit attributable to shareholders was 7.07 million yuan, up 72.79% year-on-year [1] - The company has a current ratio of 1.606 and a quick ratio of 1.448, with a debt-to-asset ratio of 47.67% [1] Financial Performance - Total revenue for Q1 2025: 87.49 million yuan, up 23.58% year-on-year [1] - Net profit: 7.07 million yuan, up 72.79% year-on-year [1] - Non-recurring net profit: 11.02 million yuan, up 60.40% year-on-year [1] - Current ratio: 1.606 [1] - Quick ratio: 1.448 [1] - Debt-to-asset ratio: 47.67% [1] Company Overview - Chengdu Olin Bio Technology Co., Ltd. was established in 2009 and is located in Chengdu [2] - The company primarily operates in the pharmaceutical manufacturing industry [2] - Registered capital: 405.93 million yuan, paid-in capital: 50 million yuan [1] - Legal representative: Fan Shaowen [1] Investment and Intellectual Property - The company has invested in 5 enterprises and participated in 741 bidding projects [2] - It holds 31 trademark registrations and 279 patent applications [2] - The company has obtained 116 administrative licenses [2]